about
Inhibition of c-Abl kinase activity renders cancer cells highly sensitive to mitoxantroneRequirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor XTGF-β-elicited induction of tissue inhibitor of metalloproteinases (TIMP)-3 expression in fibroblasts involves complex interplay between Smad3, p38α, and ERK1/2.Serpin peptidase inhibitor clade A member 1 (SerpinA1) is a novel biomarker for progression of cutaneous squamous cell carcinomaSenescence sensitivity of breast cancer cells is defined by positive feedback loop between CIP2A and E2F1.Matrix metalloproteinases in inflammation.Suppression of TGFβ and Angiogenesis by Type VII Collagen in Cutaneous SCC.Complement Component C3 and Complement Factor B Promote Growth of Cutaneous Squamous Cell Carcinoma.Long Noncoding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity.Collagens XV and XVIII show different expression and localisation in cutaneous squamous cell carcinoma: type XV appears in tumor stroma, while XVIII becomes upregulated in tumor cells and lost from microvessels.New perspectives on role of tumor microenvironment in progression of cutaneous squamous cell carcinoma.EphB2 Promotes Progression of Cutaneous Squamous Cell Carcinoma.Complement factor I promotes progression of cutaneous squamous cell carcinoma.Hypoxia-activated Smad3-specific dephosphorylation by PP2A.European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis.Significant Role of Collagen XVII And Integrin β4 in Migration and Invasion of The Less Aggressive Squamous Cell Carcinoma Cells.Squamous cell carcinoma of the skin: Emerging need for novel biomarkersClinical and Pathological Aspects of Melanoma among Children in Finland.Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma.Complement factor H: a biomarker for progression of cutaneous squamous cell carcinoma.Expression of claudin-11 by tumor cells in cutaneous squamous cell carcinoma is dependent on the activity of p38δ.European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes.MicroRNA-203 Inversely Correlates with Differentiation Grade, Targets c-MYC, and Functions as a Tumor Suppressor in cSCC.Dasatinib promotes apoptosis of cutaneous squamous carcinoma cells by regulating activation of ERK1/2.Matrix metalloproteinase-7 activates heparin-binding epidermal growth factor-like growth factor in cutaneous squamous cell carcinoma.Forty Years of the European Society for Dermatological Research as European Dermatology Goes from Strength to StrengthLong non-coding RNA PICSAR decreases adhesion and promotes migration of squamous carcinoma cells by downregulating α2β1 and α5β1 integrin expressionTumor cell-specific Serpin A1 expression in vulvar squamous cell carcinomaTIMP-3 promotes apoptosis in nonadherent small cell lung carcinoma cells lacking functional death receptor pathwayHypoxic conversion of SMAD7 function from an inhibitor into a promoter of cell invasionADAMTS5: A New Player in the Vascular FieldCollagen Turnover in Wound Repair--A Macrophage ConnectionH-Ras activation and fibroblast-induced TGF-β signaling promote laminin-332 accumulation and invasion in cutaneous squamous cell carcinomaTumour-cell-derived complement components C1r and C1s promote growth of cutaneous squamous cell carcinomap53-Regulated Long Noncoding RNA PRECSIT Promotes Progression of Cutaneous Squamous Cell Carcinoma via STAT3 SignalingComplement System in Cutaneous Squamous Cell CarcinomaLong non-coding RNAs in cutaneous biology and keratinocyte carcinomas
P50
Q27313997-A0987E57-5E52-4326-B930-F597068C8E6BQ28475714-D915E997-A3DB-424A-9BBB-7958955FF08EQ31112275-42F1B33B-35DB-48C6-A18E-961D5AF90BF9Q35168178-859F0653-3AC1-4E45-A322-75BF57B27131Q36609038-F57C5229-A081-4512-9645-FBA19062F357Q38196164-87CBAB10-23BE-4C18-AACA-23A520B9DFC2Q38383977-0BFC493A-EC62-4338-86A0-23DEA949E515Q38711402-AEEC6638-625C-487F-9BAC-02882EEABE1DQ38780371-96A9E828-D9B8-4C87-B970-1705410BF83BQ38812206-06EA08F7-EBB2-44EA-816F-98B302348154Q38895520-86605CF5-DAB1-4DD8-82D7-52A070544FDCQ38897586-134C99A9-0FC8-4E85-B329-62600161BAE0Q38960188-6787D41D-6A13-4EE8-9901-1E58FEC48D61Q39768636-F31E471B-B2D6-440D-B7D5-8F13FDC9A921Q40102390-036A85BA-A6DB-4697-A717-DE54A98A99B1Q40281329-93B04F3A-28EC-4746-87AD-40E3A1E68410Q40585796-09A48B00-AED2-494F-8456-8FC8CCDA094EQ40953852-42A60651-5222-4BDB-8B94-3EE0FAD4B48DQ41233750-D88591AA-E2B0-4D14-A80E-CFC4A083C217Q42443031-8187F61B-43D5-41D3-86AA-F73728F51E09Q47846345-CFD83C1C-D95C-4BA9-8F0C-393AEFC1B036Q49072027-563426F5-1B26-4133-B810-A72BE2EEF828Q52858516-F0B976B4-4873-42B2-92BF-48AD2DDFD26BQ53720263-B9354CEA-2779-4463-B28B-37308F2FA9F2Q54665877-516500C9-534E-454A-A30E-DC3E6F6438D0Q58039379-8DD8C8A3-40AA-484D-A6F8-082AFF70B2ECQ59800401-1C5A8864-6174-4899-A5CE-2AEE7D2C80E3Q64232812-94DF6DAA-76FB-43DC-BA3F-7B7A65997BA4Q64374916-EC23226F-849D-4F42-BA3C-B25FD7CA308DQ84413538-90CC66AE-FF7F-4343-818B-21DF7ECBCB71Q84601540-A2299AAC-BD64-4435-82D7-AFB4F0597A70Q86108596-592444E0-25DD-492E-83EB-CB0826FA5C69Q90956458-CBF54782-C672-49FC-9E28-F13D0648C58AQ91722189-BAF58D0E-D502-49C8-8C52-B356A4412646Q91981399-4C063EEE-85C6-4406-B868-71061FFEEC3AQ92084523-98B3D7F4-357C-491D-AE7B-509326F701AFQ95937028-D9919917-47D3-4CF2-976C-40DCF5B04FFE
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Veli-Matti Kähäri
@de
Veli-Matti Kähäri
@es
Veli-Matti Kähäri
@fr
Veli-Matti Kähäri
@it
Veli-Matti Kähäri
@ast
Veli-Matti Kähäri
@en
Veli-Matti Kähäri
@nl
type
label
Veli-Matti Kähäri
@de
Veli-Matti Kähäri
@es
Veli-Matti Kähäri
@fr
Veli-Matti Kähäri
@it
Veli-Matti Kähäri
@ast
Veli-Matti Kähäri
@en
Veli-Matti Kähäri
@nl
prefLabel
Veli-Matti Kähäri
@de
Veli-Matti Kähäri
@es
Veli-Matti Kähäri
@fr
Veli-Matti Kähäri
@it
Veli-Matti Kähäri
@ast
Veli-Matti Kähäri
@en
Veli-Matti Kähäri
@nl
P106
P31
P496
0000-0003-2421-9368